Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab [version 2; peer review: 2 approved]
The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with a good safety profile. Malignancies of breast, colon, head and ne...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
F1000 Research Ltd
2023-10-01
|
| Saila: | F1000Research |
| Gaiak: | |
| Sarrera elektronikoa: | https://f1000research.com/articles/11-424/v2 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|